Qure Healthcare
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Qure Healthcare sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
Qure Healthcare: 21 sponsored US clinical trials, none currently recruiting.
Qure Healthcare sponsors 21 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 20 completed. The most-studied condition in this pipeline is Diabetes, with 2 trials.
Top-decile sponsor footprint
Qure Healthcare ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
20 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
21 total, page 1 of 1
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
NCT07099001
Clinical Utility of MyProstateScore 2.0 P2
NCT05910697
Clinical Utility Study for MyProstateScore+
NCT05525806
Clinical Utility of CDMT Among VillageMD Providers
NCT05658653
Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study
NCT05910684
Clinical Utility Trial for the SomaLogic CVD-T2D Test
NCT05237271
Establishing Clinical Utility Evidence for Chronic Disease Management Testing
NCT05192590
Clinical Utility Evidence for TissueCypher®
NCT05200325
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
NCT04693793
Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial
NCT04266821
Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization
NCT04266834
Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia
NCT04204018
Assessing Opioid Care Practices Using CPV Patient Simulation Modules
NCT04080037
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
NCT03800901
Glucose Control Using 1,5-AG Testing
NCT03765164
Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients
NCT03765203
DDI Effectiveness and Clinical Awareness
NCT03581994
Adult Primary and Preventive Practice (APPP) Study
NCT02915653
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study
NCT02414438
Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study
NCT04550416
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients
NCT04266860
Therapeutic Areas
How the Qure Healthcare archive is shaped
21 indexed studies, none listed as recruiting (0% open); 20 completed (95%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Diabetes (2 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Qure Healthcare: archived-pipeline peers nationwide
Peers matched on 21 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Qure Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 archived trials
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Qure Healthcare page
21 registered trials is a research-attention snapshot, not an endorsement of Qure Healthcare or any single study.
- None of Qure Healthcare's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Diabetes is the condition Qure Healthcare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Qure Healthcare pipeline card: 21 registered trials from official public datasets.Report a data error.